# OnCo record paper-asco-hereditary-breast-cancer-guideline-jco-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-asco-hereditary-breast-cancer-guideline-jco-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-asco-hereditary-breast-cancer-guideline-jco-2020" ;
  schema:name "Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline"@en ;
  schema:description "The 2020 joint US guideline for breast cancer in people who carry an inherited fault in BRCA1, BRCA2 or another risk gene: breast-conserving surgery is allowed, bilateral mastectomy should be discussed, platinum beats taxanes in advanced disease and PARP inhibitors beat single-agent chemotherapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-asco-hereditary-breast-cancer-guideline-jco-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.20.00299>, <https://pubmed.ncbi.nlm.nih.gov/32243226/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1200/JCO.20.00299> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Tung NM, Boughey JC, Pierce LJ, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/talazoparib/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:institutions <https://onco.cc/institutions/asco/> ;
  onco:terms <https://onco.cc/technologies/germline-testing/> ;
  onco:trials <https://onco.cc/trials/olympiad/>, <https://onco.cc/trials/embraca/>, <https://onco.cc/trials/olympia/> ;
  onco:people <https://onco.cc/people/mark-robson/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-hereditary-risk/> ;
  onco:journals <https://onco.cc/journals/jco/> .